You just read:

Dystrogen Therapeutics Announces That Treatment With Dystrophin Expressing Chimeric (DEC) Cells Improves Cardiac Function in Preclinical Duchenne's Study

News provided by

Dystrogen Therapeutics Corp

Nov 05, 2019, 09:00 ET